Market revenue in 2023 | USD 38.6 million |
Market revenue in 2030 | USD 61.1 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.84% in 2023. Horizon Databook has segmented the Belgium intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
According to Belgian Health Interview Survey (HIS), in 2018, 29% of Belgians aged 15 years and above reported living with a chronic disease. This percentage increases significantly with age; 44% of the population over 75 years of age has reported living with a chronic disease.
The most commonly reported chronic diseases among the Belgian population are lower back disorders, high blood pressure, allergies, arthrosis, high blood cholesterol, and neck disorders. According to the OECD, chronic diseases are responsible for ~90% of the societal burden of disease in Belgium, including disability, contributing substantially to the overall mortality.
Chronic diseases are a major problem in this country because of its large aging population and the mortality related to these diseases is expected to increase over the next decade. These factors are expected to propel the intravenous infusion pumps market in this country over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Belgium intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into Belgium intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account